XML 78 R64.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Details)
$ / shares in Units, $ in Thousands
7 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
Plan
Period
$ / shares
shares
Dec. 31, 2017
USD ($)
Jun. 30, 2018
shares
Share-based Compensation expenses [Abstract]        
Share-based compensation | $   $ 29,940 $ 0  
Performance Unit and Option Awards [Abstract]        
Common stock, shares outstanding (in shares) | shares 24,957,309 24,957,309    
Valuation Assumptions for Determination of Fair Value [Abstract]        
Shares available for grant (in shares) | shares 2,900,000 2,900,000    
Additional Disclosures [Abstract]        
Share price (in dollars per share) $ 15.00 $ 15.00    
Manufacturing and Supply [Member]        
Share-based Compensation expenses [Abstract]        
Share-based compensation | $   $ 414    
Research and Development [Member]        
Share-based Compensation expenses [Abstract]        
Share-based compensation | $   2,583    
Selling, General and Administrative [Member]        
Share-based Compensation expenses [Abstract]        
Share-based compensation | $   $ 26,943    
Discount for Lack of Marketability [Member]        
Valuation Assumptions for Determination of Fair Value [Abstract]        
Valuation assumptions 0.34 0.34    
Volatility [Member]        
Valuation Assumptions for Determination of Fair Value [Abstract]        
Valuation assumptions 0.9 0.9    
Weighted Average Cost of Capital [Member]        
Valuation Assumptions for Determination of Fair Value [Abstract]        
Valuation assumptions 0.275 0.275    
Nonvoting Common Stock [Member]        
Share-based Compensation expenses [Abstract]        
Share-based compensation | $ [1]   $ 27,298    
Performance Unit and Option Awards [Abstract]        
Common stock, shares outstanding (in shares) | shares 4,922,353 4,922,353   4,922,353
Fair market value of non-voting shares at shares granted date | $   $ 19,123    
Withholding taxes on share-based compensation | $   $ 8,175    
Number of common shares issued (in shares) | shares   4,922,353    
Performance Units [Member]        
Performance Unit and Option Awards [Abstract]        
Number of performance units plans | Plan   2    
Restricted Stock Units [Member]        
Share-based Compensation expenses [Abstract]        
Share-based compensation | $ $ 1,085 $ 1,085 [2]    
Performance Unit and Option Awards [Abstract]        
Service period   2 years    
Number of Units [Roll Forward]        
Unvested at Plan adoption (in shares) | shares 0      
Granted (in shares) | shares 265,000      
Vested (in shares) | shares (60,000)      
Unvested, at end of period (in shares) | shares 205,000 205,000    
Weighted Average Grant Date Fair Value Per Share [Abstract]        
Unvested at Plan adoption (in dollars per share) $ 0      
Granted (in dollars per share) 14.83      
Vested (in dollars per share) 15.03      
Unvested, Balance at end of period (in dollars per share) $ 14.77 $ 14.77    
Additional Disclosures [Abstract]        
Grant date fair value | $ $ 896 $ 896    
Compensation Cost Not yet Recognized [Abstract]        
Unrecognized stock-based compensation expense | $ $ 2,568 $ 2,568    
Unrecognized compensation cost, recognition period   3 years    
Weighted average grant date fair value (in dollars per share) $ 14.83      
Restricted Stock Units [Member] | Senior Management and Board [Member]        
Additional Disclosures [Abstract]        
Vesting period   2 years    
Restricted Stock Units [Member] | key Employees [Member]        
Additional Disclosures [Abstract]        
Vesting period   3 years    
Stock Options [Member]        
Share-based Compensation expenses [Abstract]        
Share-based compensation | $ [2]   $ 1,557    
Performance Unit and Option Awards [Abstract]        
Service period   3 years    
Weighted Average Grant Date Fair Value Per Share [Abstract]        
Granted (in dollars per share)   $ 10.83    
Number of Options [Roll Forward]        
Outstanding at beginning of period (in shares) | shares 0      
Granted (in shares) | shares 1,033,000      
Exercised, Forfeited, Expired (in shares) | shares 0      
Outstanding at end of period (in shares) | shares 1,033,000 1,033,000    
Vested or expected to vest at end of period (in shares) | shares 962,000 962,000    
Exercisable at end of period (in shares) | shares 87,000 87,000    
Weighted Average Exercise Price [Abstract]        
Granted (in dollars per share) $ 14.72      
Outstanding at end of period (In dollars per share) 14.72 $ 14.72    
Vested or expected to vest at end of period (in dollars per share) 14.72 14.72    
Exercisable at end of period (in dollars per share) $ 15.02 $ 15.02    
Weighted Average Remaining Contractual Term in Years [Abstract]        
Granted 9 years 6 months 18 days      
Outstanding at end of period   9 years 6 months 18 days    
Vested or expected to vest at end of period   9 years 6 months 18 days    
Exercisable at end of period   9 years 6 months 22 days    
Aggregate Intrinsic Value [Abstract]        
Granted | $ $ 0      
Outstanding at end of period | $ 0 $ 0    
Vested or expected to vest at end of period | $ 0 0    
Exercisable at end of period | $ $ 0 $ 0    
Additional Disclosures [Abstract]        
Stock options grant, exercise price (in dollars per share) $ 14.72      
Term of award   10 years    
Share price (in dollars per share) $ 6.30 $ 6.30    
Number of vesting periods | Period   2    
Fair Value Assumptions [Abstract]        
Expected dividend yield   0.00%    
Expected volatility   90.00%    
Compensation Cost Not yet Recognized [Abstract]        
Unrecognized stock-based compensation expense | $ $ 8,845 $ 8,845    
Unrecognized compensation cost, recognition period   2 years 7 months 6 days    
Weighted average grant date fair value (in dollars per share)   $ 10.83    
Stock Options [Member] | Minimum [Member]        
Weighted Average Exercise Price [Abstract]        
Granted (in dollars per share)   6.54    
Additional Disclosures [Abstract]        
Stock options grant, exercise price (in dollars per share)   $ 6.54    
Fair Value Assumptions [Abstract]        
Expected term (years)   5 years 9 months 18 days    
Risk-free rate   2.80%    
Stock Options [Member] | Maximum [Member]        
Weighted Average Exercise Price [Abstract]        
Granted (in dollars per share)   $ 18.67    
Additional Disclosures [Abstract]        
Stock options grant, exercise price (in dollars per share)   $ 18.67    
Fair Value Assumptions [Abstract]        
Expected term (years)   6 years 1 month 6 days    
Risk-free rate   2.90%    
Stock Options [Member] | Senior Management and Board [Member]        
Additional Disclosures [Abstract]        
Vesting period   3 years    
Stock Options [Member] | key Employees [Member]        
Additional Disclosures [Abstract]        
Vesting period   3 years    
Employee Stock Purchase Plan [Member]        
Employee Stock Purchase Plan [Abstract]        
Number of shares reserved for issuance (in shares) | shares   250,000    
Purchase price of common stock as percentage of fair market value   85.00%    
[1] Non-Voting Common Share Issuance
[2] Share-Based Compensation Equity Awards